Publication
Article
BioPharm International
Author(s):
PDUFA III boost manufacturer fees to cover postapproval surveillance and streamline the FDA review process
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.